Cannabis explained
EKOCAN Explained: What Germany’s Cannabis Study Has Found So Far
What have Germany’s cannabis reforms meant for drug use, public health, young people and the black market?
For Professionals
Prescribing, clinical practice and regulatory change for the clinicians building this field.
Latest in For Professionals
Cannabis explained
Can Cannabis Make ADHD Worse? What the Evidence Says About the Risks
Cannabis may help some people with ADHD manage symptoms such as restlessness and impulsivity – but research suggests it could make other symptoms worse.
Cannabis explained
Medical Cannabis in Northern Ireland: Access, Law and Clinics in 2026
Medical cannabis has been legal on prescription in Northern Ireland since 1 November 2018.
Cannabis explained
Medical Cannabis for Autism in the UK: Evidence, Access and What Parents Ask
Interest in medical cannabis for autism is growing among patients, families and clinicians, but research has yet to establish whether it is an effective treatment.
Advocacy
New White Paper Calls for NHS Cannabis Pilot and Parliamentary Inquiry Into the Industry
In the eight years since, the NHS has issued just five prescriptions for unlicenced specials cannabis medicines, creating a two-tier system with access only to those who can afford to pay for it.
Cannabis explained
Why UK Employers Need a Medical Cannabis Policy
‘Without a clear policy, employers are more likely to be influenced by their understanding of recreational drug use.’
Industry
Ananda Pharma Doses First Patient in NIHR-Backed CIPN Trial
The study is evaluating MRX1, the company’s proprietary CBD-based oral solution, as a treatment for chemotherapy-induced peripheral neuropathy (CIPN).
Industry
Nine of the 10 Top CBPM Prescribers Are Pharmacists, UK FOI Data Shows
Pharmacist independent prescribers accounted for 61.9% of the total items prescribed between January 2019 and May 2025.
Industry
UK Medical Cannabis Patient Numbers Set to Reach 140,000 in 2026, Industry Report Finds
UK imports of the medical cannabis and the range of products available to patients both doubled in 2025.
Industry
Ananda Pharma Confirms Safety of CBD Drug, as Clinical Pain Trials Approach
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
Medical cannabis
The Power of Patient Stories: How Lived Experience is Shifting Medical Cannabis Stigma
Despite medical cannabis being legal in the UK for almost eight years, many patients remain hesitant or unsure about whether it is right for them. While awareness of the legality […]
Advocacy
What Happens If You’re Stopped by Police With a Prescription? The Reality Facing Cannabis Patients
Medical cannabis has been legal in the UK since 2018, but for many patients, taking or carrying their prescribed medication in public still comes with uncertainty. Since launching its legal […]
Industry
Cannabis Europa Heads to London Amid €1.5 Billion European Market Surge
More than 70 international speakers and over 1000 delegates are set to convene on London next month for policy debates, high-level networking, and the 2026 Business of Cannabis Awards.
Directory
Find or refer to a provider
Browse verified UK medical cannabis clinics and pharmacies — online and in person.
Upcoming Symposiums
Cannabis Health Symposium
Evidence-led education for clinicians, industry and patient advocates — across Europe.
Every ticket includes 12 months’ free MCCS membership — worth up to £120.
See all events- View event
4 November 2026
Frankfurt · Mainhaus
- View event
26 November 2026
London · Conway Hall